MREO vs JNJ: Which Stock is Better?
Side-by-side comparison of Mereo BioPharma Group PLC ADR and Johnson & Johnson in 2026
MREO
Mereo BioPharma Group PLC ADR
—
JNJ
Johnson & Johnson
$232.77
Key Metrics Comparison
| Metric | MREO | JNJ | Winner |
|---|---|---|---|
| Market Cap | $49.99M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze MREO
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MREO or JNJ a better investment?
Comparing MREO and JNJ: Mereo BioPharma Group PLC ADR has a market cap of $49.99M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MREO and JNJ?
MREO (Mereo BioPharma Group PLC ADR) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MREO or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MREO or JNJ?
Both MREO and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: MREO or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: MREO or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $49.99M for MREO.
Should I buy MREO or JNJ in 2026?
Both MREO and JNJ have investment merit. MREO trades at $N/A while JNJ trades at $232.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MREO and JNJ stock?
Key differences: Market Cap ($49.99M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy MREO or JNJ in 2026?
The choice between MREO and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between MREO and JNJ?
MREO (Mereo BioPharma Group PLC ADR) has a market cap of $49.99M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.